The PE Ratio as of September 2024 (TTM) for Aridis Pharmaceuticals, Inc. (ARDS) is -0.01

According to Aridis Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.69% compared to the average of -3.22 of the last 4 quarters.

Aridis Pharmaceuticals, Inc. (ARDS) Historical PE Ratio (quarterly & annually)

How has ARDS PE Ratio performed in the past?

The mean historical PE Ratio of Aridis Pharmaceuticals, Inc. over the last ten years is -3.31. The current -0.01 PE Ratio has changed -69.77% with respect to the historical average. Over the past ten years (40 quarters), ARDS's PE Ratio was at its highest in in the June 2023 quarter at 0.16. The PE Ratio was at its lowest in in the June 2018 quarter at -18.01.

Aridis Pharmaceuticals, Inc. (ARDS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aridis Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aridis Pharmaceuticals, Inc. (ARDS) Average PE Ratio

How has ARDS PE Ratio performed in the past?

The current PE Ratio of Aridis Pharmaceuticals, Inc. (ARDS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aridis Pharmaceuticals, Inc. (ARDS) PE Ratio vs. Peers

How is ARDS’s PE Ratio compared to its peers?

Aridis Pharmaceuticals, Inc.’s PE Ratio is greater than Akari Therapeutics, Plc (-1.60), greater than Aditxt, Inc. (-0.02), greater than ABVC BioPharma, Inc. (-0.68), greater than Acasti Pharma Inc. (-2.39), greater than Sigilon Therapeutics, Inc. (-1.90), greater than Reviva Pharmaceuticals Holdings, Inc. (-0.94), greater than ZyVersa Therapeutics, Inc. (-0.09), greater than Kiromic BioPharma, Inc. (-0.12), greater than Unicycive Therapeutics, Inc. (-0.49), greater than Avenue Therapeutics, Inc. (-0.30), greater than Hoth Therapeutics, Inc. (-0.92), greater than Revelation Biosciences, Inc. (-0.09), greater than NeuroBo Pharmaceuticals, Inc. (-0.75), greater than Virax Biolabs Group Limited (-1.10), greater than Reviva Pharmaceuticals Holdings, Inc. (-0.94), greater than Eyenovia, Inc. (-0.77), greater than Cognition Therapeutics, Inc. (-0.77), greater than TransCode Therapeutics, Inc. (-0.10), greater than Kodiak Sciences Inc. (-0.70), greater than Dermata Therapeutics, Inc. (-0.15),

Build a custom stock screener for Aridis Pharmaceuticals, Inc. (ARDS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aridis Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aridis Pharmaceuticals, Inc. (ARDS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aridis Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.